drugset / Trial / NCT02314533

Evaluate the Efficacy of Fenofibrate on Microalbuminuria

NCT02314533

Phase 4 Unknown 200 enrolled Beijing Chao Yang Hospital
NaSingle-groupOpen-labelTreatment

Summary

The investigators design this prospective, open-label, parallel, controlled study to investigate fenofibrate's effect on microalbuminuria reduction and serum creatinine on top of statin therapy in Chinese hypertriglyceridemic patients with type 2 diabetes.

Timeline

Start
2014-12
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 200 mg Oral

Indications